diffuse

BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) -- Overland ADCT BioPharma, a joint venture of Overland Pharmaceuticals (CY) Inc. and ADC Therapeutics…

10 July 2023 Biodexa Ltd(“Biodexa” or the “Company”) Completion of Enrolment and Treatment in the Phase 1 Study of MTX110 in theTreatment of Children with Newly Diagnosed Diffuse Midline…

<!-- Name:DistributionId Value:8846053 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

The FDA granted accelerated approval to epcoritamab (Epkinly) for the treatment of adults with relapsed or…

<!-- Name:DistributionId Value:8739359 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

SAN DIEGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers…

Second-line treatment for diffuse large B-cell lymphoma (DLBCL) got a big boost in 2022 with…

Data demonstrated robust anti-tumor activity of BMF-219 and mechanistic evidence for novel inhibition of menin protein in preclinical models of Diffuse Large B-cell Lymphoma (DLBCL) and…

-- Novel biomarker will be used to identify patients in genetically defined subgroup associated with poorer outcomes -- Study will evaluate SYK inhibitor both in patients with wild-type…

Physician’s Briefing Staff THURSDAY, May 26, 2022 (HealthDay News) -- A prognostic model based on clinical parameters has been developed and validated…